| 摘要 |
<p>The present invention relates to compounds of formula (I) wherein HET is either (A) or (B) and pharmaceutical compositions containing a therapeutically effective amount of the compounds in combination with a pharmaceutically acceptable carrier and a method for treating diseases mediated by platelet activating factor.</p> |
